The small GTP-binding protein Rac is a downstream eector of the oncogene product p21-ras. Rac is involved in actin polymerization, Jun kinase activation, and intracellular superoxide anion production, through distinct pathways in tumor cells. Here we investigated the role of activated Rac in the response of tumor cells to apoptosis triggered by anti-cancer drugs or the cell surface death receptor CD95. Using M14 melanoma cells stably transfected with a constitutively active form of Rac1, we show that activated Rac inhibits tumor cell response to apoptosis. The inhibitory eect of activated Rac on apoptotic signaling is mediated by the interaction of Rac with intracellular oxidase and the subsequent production of superoxide, which is supported by experiments performed with M14 and NIH3T3 cells transiently transfected with the loss-of-function mutants of Rac in an activated RacV12 background. Consistent with these ®ndings, we also demonstrate that inhibition of the Rac pathway in the HaRas-expressing T24 bladder carcinoma cell line induces a decrease in superoxide anion concentration, and results in a signi®cant increase in tumor cell sensitivity to apoptosis. These ®ndings demonstrate the existence of a novel Racdependent survival pathway mediated by intracellular superoxide in tumor cells. Oncogene (2001) 20, 6263 ± 6268.
Whereas, the role of growth factors and products of proto-oncogenes have been linked to the enhanced proliferative capacity of tumor cells, there is growing evidence to implicate these cellular proteins in the regulation of apoptotic signaling in tumor cells. A classical example is the 21 kD protein encoded by the ras oncogene (p21-ras), one of the most important oncogenes involved in human tumorigenesis. Almost 30% of human tumors harbor mutations in the p21-ras (Bos, 1988; Downward, 1990) , and depending upon the downstream eector(s) activated by the oncogenic Ras protein, both positive and negative regulatory eect(s) on the apoptotic pathway have been demonstrated. The downstream targets of Ras include the kinase Raf, the p110 catalytic sub-unit of phosphoinositide3-kinase (PI3-kinase), and the Ral GTPase exchange factor Ral-GDS (Downward, 1998) . Activation of the PI3-kinase leads to the activation of the Rac and Akt/ PKB pathways. Whereas, induction of Akt/PKB kinase is involved in tumor cell survival (Marte and Downward, 1997) , Rac activation is associated with mitogenic signaling in transformed ®broblasts (Irani and Goldschmidt-Clermont, 1998; Irani et al., 1997) . Two recent reports have added a newer dimension to the downstream eects triggered by Rac activation. In the ®rst communication Rac activation has been shown to inhibit Ras-induced apoptosis, (Joneson and Bar-Sagi, 1999) , and a second report demonstrates that insulinreceptor mediated survival signaling also is associated with Rac activation, independent of the Akt/PKB pathway (Boehm et al., 1999) . Hence, these data suggest that activation of Rac, in addition to regulating cell proliferation, could also regulate tumor cell response to apoptotic triggers.
To date, two rac genes rac1 and rac2 have been identi®ed. Rac1 is ubiquitously expressed, however, rac2 expression is restricted to cells of the myeloid and lymphoid lineages (Didsbury et al., 1989) . These genes encode for low molecular weight GTP-binding proteins, ®rst identi®ed in HL60 leukemia cells. Stimulated by the ®ndings implicating Rac activation in regulating cellular response to apoptosis, we set out to investigate the eect of Rac1 activation on the sensitivity of tumor cells to apoptotic signaling. In order to do so, we used the human melanoma cell line M14, which does not express the oncogenic form of Ras. M14 cells were stably transfected using the pIREShyg bi-cistronic expression vector encoding for a myc-tagged constitutively active mutant of Rac1 (pIRESRacV12). After 3 to 4 weeks of selection with 250 mg/ml hygromycine, expression of the myc-tagged protein was con®rmed by Western blot analysis in the derived resistant cell line (M14RacV12). As a control, M14 cells were transfected with the parental pIREShyg vector lacking the Rac1V12 insert (M14pIRES); Western blot analysis with an anti-myc antibody con®rmed the absence of the myc-tagged protein in the control cells (Figure 1a ). In addition, the myc-RacV12 protein was indeed, GTP bound while no GTP bound Rac could be detected in the vector transfected cell line (Figure 1b) .
The sensitivity of M14pIRES and M14RacV12 cell lines to apoptosis was next assessed by incubating cells with increasing concentrations of staurosporine, a known inducer of apoptosis (Jacobson et al., 1993) . Expression of RacV12 resulted in a virtually complete rescue of cells (495% survival) following exposure to 0.25 mM staurosporine, and 4100% increase in the surviving fraction at 0.5 mM staurosporine as compared to the vector transfected M14 cells (Figure 2a) . Furthermore, we provide evidence that the enhanced survival exhibited by M14RacV12 cells was indeed due to inhibition of the apoptotic pathway. Analyses of DNA fragmentation and caspase activation, two characteristic hallmarks of apoptosis, revealed that the fraction of cells in sub-diploid G1 phase (20% as compared to 50%) and caspase 3 activity were signi®cantly lower in M14RacV12 cells as compared to the M14pIRES cells following incubation with 0.5 mM staurosporine (Figure 2b,c) . Similar results were obtained upon exposure of M14RacV12 and M14pIRES to 40 mM etoposide, a commonly used chemotherapeutic drug and widely used inducer of apoptosis (data not shown) (Walker et al., 1991) . These data suggest that expression of a constitutively active form of Rac1 signi®cantly reduces tumor cell sensitivity to apoptosis. ), through distinct eector pathways (Campbell et al., 1998) . Therefore, in order to identify the eector function of Rac involved in suppressing the apoptotic signal, we used partial myc-tagged loss-offunction mutants containing speci®c amino acid substitutions in the activated RacV12 background cloned into the pIREShyg vector. The RacV12L37 mutant activates JNK but is defective in inducing actin polymerization, whereas the RacV12H40 mutant induces actin polymerization but is defective in JNK activation. However, both of these mutations do not interfere with the ability of active Rac to generate intracellular O 2 .7 (Joneson and Bar-Sagi, 1998) . M14 cells were co-transfected with the pCMVbgal plasmid, which encodes for the b-galactosidase protein (b-gal) and either the pIREShyg empty vector (pIRES) as control or pIRESRacV12, pIRESRacV12L37 or pIRESRacV12H40. We chose to co-express the b-gal protein with the Rac mutant proteins in order to circumvent the problem of non-transfected cells when assessing sensitivities to apoptosis. Using expression of b-gal as a marker, only transfected cells are analysed for response to apoptotic stimuli. Forty-eight hours post-transfection, sensitivity to apoptosis of pIRES, pIRESRacV12 and pIRESRacV12H40 or L37 transfected cells was assessed by measuring the b-gal activity in cells incubated with or without 40 mM etoposide for an additional 24 h. Per cent survival was calculated as the (b-gal activity of transfected cells incubated with etoposide/b-gal activity of transfected cell incubated without etoposide)6100. Our results showed that overexpression of either of the mutants (M14/RacV12H40 and M14/RacV12L37) inhibited etoposide induced apoptosis in M14 cells, and the degree of inhibition was comparable to the one measured in M14 cells transfected with RacV12 (Figure 3a ,b). It should be pointed out that the transient expression (48 h posttransfection) of the pIRES RacV12 mutants was not signi®cantly dierent ( Figure 3a ). Hence the dierence in tumor cell response to the apoptotic trigger could not be attributed to dierences in the Rac mutant proteins' expression. These results indicate that actin polymerization and JNK activation are not essential for the apoptosis inhibitory activity of Rac1. However, as both the mutant proteins are still functional in their ability to generate Rac-dependent intracellular O 2 .7
, it is plausible that the inhibition of the apoptosis execution could be a function of intracellular O 2 .7 production.
One of the mechanisms of intracellular O 2 .7
production in phagocytic cells is the nicotinamide adenine dinucleotide phosphate (NADPH)-dependent reduction of molecular oxygen by the membrane bound NADPH oxidase complex (Dahlgren and Karlsson, 1999) . In non-phagocytic cells, the proteins responsible for generating O 2 .7 are less well de®ned, but were shown to be regulated by Rac1 (Finkel, 1999;  Irani and Goldschmidt-Clermont, 1998; Irani et al., Figure 1 M14 cells (gift from Dr Armando Bartolazzi, Oncologia Clinica e Sperimentale, Rome, Italy) were stably transfected with an empty pIRES1hyg (M14pIRES) or the same vector encoding the myc-RacV12 protein (M14RacV12). Stable transfection was performed using the SuperFect Transfection Reagents from QIAGEN Gmbh (Germany) according to the vendor's instructions. Resistant cell lines were selected using 250 mg/ml hygromycine (Boehringer Mannheim, Indianapolis, IN, USA). (a) Myc-tagged RacV12 protein in the M14RacV12 and M14pIRES cell lines was detected by Western blotting using 2 mg/ml of a mouse monoclonal anti-human myc epitope antibody (Boehringer Mannheim, Indianapolis, IN, USA). (b) GTP bound Rac was detected using the Rac activation assay kit (Upstate Biotechnology, Lake Placid, NY, USA) in accordance with the vendor's instructions using GST coupled PAK (GST-PAK pull down). Moreover, as control 100 mg of lysat before GST-PAK pulldown was also analysed (total). Rac protein in GST-PAK pulldown and total lysat was detected by Western blotting using 1 mg/ml of a monoclonal anti-human Rac antibody (Upstate Biotechnology Lake Placid, NY, USA) 1997). In this regard, the critical role of histidine 103 and lysine 166 of Rac1 protein, in the activation of NADPH oxidase and the resultant O 2 .7 production by Rac has been established (Toporik et al., 1998) . Hence, in order to assess if Rac1 interaction with oxidase was indeed responsible for the inhibition of apoptosis in cells expressing RacV12, the H103 and K166 mutants were cloned into the pIRES vector in a RacV12 background. M14 cells were then transfected and sensitivity of the transfected cells to etoposide-induced apoptosis was investigated using the b-gal survival assay as above. Unlike transfection with the pIRESRacV12 plasmid, transfection with pIRESRacV12-H103A or pIRESRacV12K166E did not inhibit apoptosis triggered by etoposide as shown in Figure  3a ,b. In addition, it is unlikely that the eect of Rac V12 expression on apoptosis, could be explained by the tumorigenic background of M14 cells. Indeed, expression of RacV12 also inhibited staurosporine-induced apoptosis in the nontumorigenic NIH3T3 ®broblast cell line, and, similar to M14 cells, staurosporine induced apoptosis was inhibited in NIH3T3 cells by mutants of RacV12 that retain functional NADPH oxidase activating property and induce O 2 .7 production (Figure 3b ). It should be pointed out that, similar to our results shown with M14 cells (Figure 3a) , the level of expression of Rac mutants following transient transfection in NIH3T3 cells was not signi®cantly dierent (data not shown). Taken together, these ®ndings demonstrate that Rac interaction with NADPH oxidase is involved in the inhibition of apoptotic signaling, thus strongly implicating intracellular O 2
.7 production in Rac1-induced inhibition of apoptosis in normal and neoplastic cells. Corroborating these ®ndings, a 38+9% increase in the steady state level of intracellular O 2 .7 was obtained in the stably transfected M14RacV12 cell line compared to the M14pIRES cells (Figure 4a ). In addition, sensitivity of the M14RacV12 cell line to etoposide-induced apoptosis, measured by caspase 3 activity and crystal Figure 2 (a) Survival of M14RacV12 and M14pIRES cell lines following incubation with increasing concentrations of staurosporine for 18 h was assessed by crystal violet staining as described elsewhere (CleÂ ment and Stamenkovic, 1996) . Cell survival was calculated as: (mean of triplicate OD values at 595 nm of cells incubated with the speci®c trigger/mean of triplicate OD values of cells incubated in control medium)6100. Data represent per cent of cell survival+s.e. of three independent experiments done in triplicate. (b) DNA fragmentation was detected by propidium iodide staining and measured by the per cent of cells in the sub-G1 phase after 12 h incubation with 0.5 mM staurosporine as described before . Data represent per cent of cells in the sub-G1 phase+s.e. from two independent experiments done in duplicate. (c) Time dependent DEVDase activity in M14pIRES and M14RacV12 cell lines incubated with 0.5 mM staurosporine. DEVDase activity was measured as described previously (Pervaiz et al., 1999b) . Data are shown as DEVDase activity expressed as fold increase over control cells left for the same period of time without staurosporine+s.e. of three independent experiments done in duplicates violet staining, could be increased to the level of the M14pIRES cell line in the presence of EUK-8, a cell permeable superoxide dismutase mimic, (Musleh et al., 1994) (Figure 4b ). These ®ndings are in agreement with recent data showing that Rac1 suppresses the proapoptotic activity of Ras via NADPH oxidasedependent O 2 .7 production (Joneson and Bar-Sagi, 1999) , and previous reports from our laboratory that intracellular level of O 2
.7 regulates tumor cell sensitivity to a variety of apoptotic triggers (CleÂ ment and Pervaiz, 1999; CleÂ ment and Stamenkovic, 1996; Pervaiz et al., 1999a) .
Rac1 is one of the downstream targets of the oncogene ras. Therefore, we next asked if in the light of our ®ndings, resistance to apoptosis in tumor cells expressing an oncogenic Ras protein could be associated with Rac1 activation. In order to investigate that, we selected the human bladder carcinoma cell line T24 as the model cell line due to two main reasons. Firstly, T24 bladder carcinoma was one of the ®rst cell lines reported to have an oncogenic Ras mutation (Capon et al., 1983 ; Figure 3 (a) Myc-tagged RacV12 was ampli®ed from pEXVV12Rac, RacV12H103 and RacV12K166 from pGEX2TRacH103 and pGEX-2TRacK166 and RacV12H40 and RacV12L37 from pCGTRacV1240H and pCGTRacV1237L. For all ampli®cations, a sense oligonucleotide with a myc epitope sequence and a BamH-I restriction enzyme site (5'-CAC GCG GGA TCC ATG GAG CAG AAG CTG ATC TCC GAG GAG GAC CTG CAG GCC ATC AAG TGT GTG GTG GTG GGA GAT GTG GCC GTG-3') and an anti-sense oligonucleotide with a Not1 restriction enzyme site (5'-CAC CGC GAT GGC GGC CGC TTA CAA CAG CAG GCA TTT TCT CTT-3') were used. All PCR ampli®ed full-length cDNAs were subsequently cloned into the pIRES1hyg vector (Clonetech Laboratories, Inc., Palo Alto, CA, USA) in the BamH1/Not1 sites. DNA sequence of the inserts were veri®ed by the Core Sequencing Facility of the National University of Singapore. Transient transfections of M14 cells were performed using the SuperFect Transfection Reagents from QIAGEN Gmbh (Germany) following the vendor's instructions using 3.5 mg of the appropriate pIRESRacV12 mutant plasmid, 0.5 mg of the pCMVb plasmid (Clonetech Laboratories, Inc., Palo Alto, CA, USA) encoding for the bgalactosidase protein (b-gal), and 20 ml of the SuperFect Transfection Reagent. Forty-eight hours post-transfection cell lysates were collected and expression of the transiently expressed RacV12 mutant proteins in 300 mg of total lysat was detected by Western blotting using 4 mg/ml of a monoclonal anti-human myc epitope antibody (Boehringer Mannheim, Indianapolis, IN, USA). Transiently transfected cells were also exposed to 40 mM etoposide for 24 h and percentage survival was calculated as: ((bgal activity/mg of protein of transfected cells incubated with etoposide)/(b-gal activity/mg of protein of transfected cells incubated without etoposide)). b-gal activity was measured using the Galacto-Star mammalian reporter Kit (TROPIX, Bedford, MA, USA). Protein concentration was determined using the Coomasie Plus protein assay reagent from Pierce (Pierce Chemical Company, Rockford, IL, USA). (b) Using the same protocol described in (a) NIH3T3 and M14 cells were transfected with the RacV12 mutant proteins. Forty-eight hours post-transfection apoptosis was triggered by 1 mM staurosporine (NIH3T3 cells) or 40 mM etoposide (M14 cells) for 12 h and 24 h, respectively. Survival was calculated as per cent of b-gal activity as described in (a). Results shown are the mean+s.e. of four independent experiments .7 was measured in M14RacV12 and M14pIRES cell lines using the lucigenin-based chemiluminescence assay as previously described (CleÂ ment and Stamenkovic, 1996) . Chemiluminescence was monitored in a TD-20/20 Luminometer (Turner Designs, Sunnyvale, CA, USA). Data represent the mean+s.e. of four independent measurements. (b) M14pIRES and M14RacV12 cell lines were incubated with 40 mM etoposide for 24 h with or without 30 mM EUK-8. DEVDase activity was measured at dierent time point as described in Figure 2c and is represented as fold increase over control cells left for the same period of time without etoposide Taparowsky et al., 1982) , and secondly our previous data clearly implicated intracellular O 2 .7 in the natural resistance of T24 cells to CD95-mediated apoptosis (CleÂ ment and Stamenkovic, 1996) . Indeed, transient transfection of T24 cells with a dominant negative mutant of Rac1 (T24/RacN17) (Figure 5a ) signi®cantly decreased intracellular O 2 .7 concentration (Figure 5b ) with a concomitant increase in tumor cell sensitivity to CD95-mediated apoptosis, as shown by a signi®cant decrease in cell survival (measured by the b-gal survival assay), following induction of apoptosis for 24 h (Figure 5c ). Similar results were obtained with 40 mM etoposide as the apoptotic trigger (data not shown). In an earlier report we demonstrated that the increase in sensitivity to CD95-mediated apoptosis obtained by prior incubation of T24 cells with the NADPH inhibitor diphenyliodanium (DPI) could be reverted by inhibiting the principal cytosolic O 2 .7 scavenger, Cu/Zn SOD, with diethyldithiocarbamate (DDC) (CleÂ ment and Stamenkovic, 1996) . In a similar manner, the increase in sensitivity to CD95-mediated apoptosis by RacN17 expression in T24 cells was reverted in the presence of 1 mM DDC ( Figure 5C ). These results show that the resistance of oncogenic Ras-expressing tumor cells to apoptosis could be associated with activation of Rac1 and the resultant increase in the steady state level of intracellular O 2 .7
. Moreover, we demonstrate that activation of Rac1 does not only suppress the proapoptotic activity of Ras (Joneson and Bar-Sagi, 1999 ) but also drug-and receptor-induced apoptosis in human tumor cells.
The mechanism involved in the inhibition of apoptosis by intracellular O 2 .7 is still unclear. One probable mechanism suggested for Rac-induced inhibition of apoptosis is O 2 .7 -mediated NF-kB activation (Joneson and Bar-Sagi, 1999) . However, in a previous report, we demonstrated that NF-kB activity did not correlate with the sensitivity of T24 cells to CD95-mediated apoptosis. Moreover, using the DNA gel mobility shift assay, no NF-kB DNA binding activity could be detected in T24 cells ). An alternative explanation could be oxidative inhibition of caspase activation/ activity, the central executioners of apoptotic cell death (for review see Thornberry and Lazebnik, 1998) . To this eect, it has been shown that caspases contain an active site cystein nucleophile that is prone to oxidation, which could explain for the optimal activation/activity of caspases in a reduced intracellular environment (Hirpara et al., 2001) . Therefore, any deviation from the optimal reducing conditions, as could be predicted with an increased intracellular O 2 .7 concentration, could be detrimental to caspases and render them inactive (Chandra et al., 2000) .
In summary, despite the need for further investigations to determine the exact mechanism involved in inhibition of apoptosis by increased steady state Figure 5 Myc-tagged RacN17 was ampli®ed from pEXVN17Rac and cloned in the pIRES vector as described in Figure 3 . (a) T24 cells were transiently transfected with an empty pIRES vector (T24/pIRES,) or with the pIRES RacN17 vector (T24/RacN17). Forty-eight hours post-transfection intracellular (a) cell lysates were obtained and expression of the transiently expressed RacN17 proteins was detected by Western blotting as described in Figure 3 (a). O 2 .7 level was measured as described in Figure 4 (a). In order to avoid variation in cell numbers due to transfection procedure, measurement of intracellular O 2 .7 level was standardized per mg of total protein and the reading was taken over 3 min. Data are mean of three independent transfections done in duplicate+s.e. (c) Survival was assessed after 24 h incubation with 0.125 mg/ml of anti-CD95 antibody using the b-gal assay as described in Figure  3 in the presence or absence of 1 mM diethyldithiocarbamate (DDC). Results are the mean+s.e. of three experiments intracellular O 2 .7 concentration, our results demonstrate a new role for the Rac/oxidase/O 2 .7 signaling pathway, previously shown to be associated with mitogenic signaling in transformed ®broblasts (Irani and Goldschmidt-Clermont, 1998; Irani et al., 1997) . Scavenging intracellular O 2 .7 produced by activation of the Rac pathway, in addition to inhibiting proliferation, may also increase tumor cell sensitivity to a variety of apoptotic triggers, including anti-cancer drugs and the CD95-receptor. The resultant change in the intracellular redox state of the tumor cells could then be exploited as a novel approach for the development of eective anti-cancer drugs
